Literature DB >> 9627405

Efficient production of mannan-degrading enzymes by the basidiomycete Sclerotium rolfsii.

A Sachslehner1, D Haltrich, G Gübitz, B Nidetzky, K D Kulbe.   

Abstract

Sclerotium rolfsii CBS 191.62 was cultivated on a number of carbon (C) sources, including mono- and disaccharides, as well as on polysaccharides, to study the formation of different mannan-degrading enzyme activities. Highest levels of mannanase activity were obtained when alpha-cellulose-based media were used for growth, but formation of mannanase could not be enhanced by employing galactomannan as the only carbon source. Although both xylanase and cellulase formation was almost completely repressed when S. rolfsii was grown on more readily metabolizable carbohydrates, including glucose or mannose, considerable amounts of mannanase activity were secreted under these growth conditions. Enhanced mannanase production only commenced when glucose was depleted in the medium. The maximal mannanase activity of 240 IU/mL obtained in a laboratory fermentation is remarkable. Mannanase activity formed under these derepressed conditions could be mainly attributed to one major, acidic mannanase isoenzyme with a pI value of 2.75.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9627405     DOI: 10.1007/bf02920205

Source DB:  PubMed          Journal:  Appl Biochem Biotechnol        ISSN: 0273-2289            Impact factor:   2.926


  2 in total

1.  Purification and characterization of cellobiose dehydrogenase from the plant pathogen Sclerotium (Athelia) rolfsii.

Authors:  U Baminger; S S Subramaniam; V Renganathan; D Haltrich
Journal:  Appl Environ Microbiol       Date:  2001-04       Impact factor: 4.792

2.  Optimization and purification of mannanase produced by an alkaliphilic-thermotolerant Bacillus cereus N1 isolated from Bani Salama Lake in Wadi El-Natron.

Authors:  Ebaa Ebrahim El-Sharouny; Nabil M K El-Toukhy; Nermeen Ahmed El-Sersy; Abeer Abd El-Aal El-Gayar
Journal:  Biotechnol Biotechnol Equip       Date:  2015-01-13       Impact factor: 1.632

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.